Advanced search
Publication Cover
Acta Oncologica Volume 37, 1998 - Issue 4
Journal homepage
152
Views
14
CrossRef citations to date
0
Altmetric
Research Article

Influence of Droloxifene on Metastatic Breast Cancer as First-Line Endocrine Treatment

Helge Haarstad From the Department of Oncology, Trondheim University Hospital, Trondheim (H. Haarstad), Department of Oncology, Haukeland University Hospital, Bergen (P.E. Lonning), Department of Oncology, The Norwegian Radium Hospital, Oslo (S. Gundersen, S. Kvinnsland), Department of Oncology, Tromso University Hospital, Tromso (E. Wist), and the Department of Oncology, Ulleva l University Hospital, Oslo (N. Raabe), Norway
,
Per E. Lønning From the Department of Oncology, Trondheim University Hospital, Trondheim (H. Haarstad), Department of Oncology, Haukeland University Hospital, Bergen (P.E. Lonning), Department of Oncology, The Norwegian Radium Hospital, Oslo (S. Gundersen, S. Kvinnsland), Department of Oncology, Tromso University Hospital, Tromso (E. Wist), and the Department of Oncology, Ulleva l University Hospital, Oslo (N. Raabe), Norway
,
Stein Gundersen From the Department of Oncology, Trondheim University Hospital, Trondheim (H. Haarstad), Department of Oncology, Haukeland University Hospital, Bergen (P.E. Lonning), Department of Oncology, The Norwegian Radium Hospital, Oslo (S. Gundersen, S. Kvinnsland), Department of Oncology, Tromso University Hospital, Tromso (E. Wist), and the Department of Oncology, Ulleva l University Hospital, Oslo (N. Raabe), Norway
,
Erik Wist From the Department of Oncology, Trondheim University Hospital, Trondheim (H. Haarstad), Department of Oncology, Haukeland University Hospital, Bergen (P.E. Lonning), Department of Oncology, The Norwegian Radium Hospital, Oslo (S. Gundersen, S. Kvinnsland), Department of Oncology, Tromso University Hospital, Tromso (E. Wist), and the Department of Oncology, Ulleva l University Hospital, Oslo (N. Raabe), Norway
,
Nils Raabe From the Department of Oncology, Trondheim University Hospital, Trondheim (H. Haarstad), Department of Oncology, Haukeland University Hospital, Bergen (P.E. Lonning), Department of Oncology, The Norwegian Radium Hospital, Oslo (S. Gundersen, S. Kvinnsland), Department of Oncology, Tromso University Hospital, Tromso (E. Wist), and the Department of Oncology, Ulleva l University Hospital, Oslo (N. Raabe), Norway
&
Stener Kvinnsland From the Department of Oncology, Trondheim University Hospital, Trondheim (H. Haarstad), Department of Oncology, Haukeland University Hospital, Bergen (P.E. Lonning), Department of Oncology, The Norwegian Radium Hospital, Oslo (S. Gundersen, S. Kvinnsland), Department of Oncology, Tromso University Hospital, Tromso (E. Wist), and the Department of Oncology, Ulleva l University Hospital, Oslo (N. Raabe), Norway
Pages 365-368 | Published online: 08 Jul 2009

References

  • Jordan VC. A current view of tamoxifen for the treatment and prevention of breast cancer. Br J Pharmacol 1993; 339: 71–85.
  • Goldhirsch A, Gelber RD. Endocrine therapies of breast cancer. Semin Oncol 1996; 23: 494–505.
  • Jaiyesimi IA, Buzdar AU, Decker DA, Hortobagyi GN. Use of tamoxifen for breast cancer: twenty-eight years later. J Clin Oncol 1995; 13: 513–29.
  • Hasmann M, Rattel B, Loser R. Preclinical data for drolox-ifene. Cancer Lett 1994; 84: 101–16.
  • Haarstad H, Gundersen S, Wist E, Raabe N, Melia O, Kvinnsland S. Droloxifene-a new anti-estrogen. A phase II study in advanced breast cancer. Acta Oncol 1992; 31: 425–8.
  • Hayward JL, Carbone PP, Heuson JC, Kumaoka S, Segaloff A, Rubens RD. Assessment of response to therapy in ad-vanced breast cancer. Eur J Cancer 1977; 13: 89–94.
  • Geisler J, Haarstad H, Gundersen S, Raabe N, Kvinnsland S, Lonning PE. Influence of treatment with the anti-oestrogen 3-hydroxytamoxifen (droloxifene) on plasma sex hormone levels in postmenopausal patients with breast cancer. J En-docrinol 1995; 146: 359–63.
  • Grill HJ, Pollow K. Pharmacokinetics of droloxifene and its metabolites in breast cancer patients. Am J Clin Oncol 1991; 14 (Suppl 2): 21–9.
  • Lonning PE. New endocrine drugs for treatment of advanced breast cancer. Acta Oncol 1990; 29: 379–86.
  • Roos WK, Oeze L, Loser R, Eppenberger U. Antiestrogen action of 3-hydroxy-tamoxifen in the human breast cancer cell line MCF-7. J Natl Cancer Inst 1983; 71: 55–9.
  • Eppenberger U, Wosikowski K, Ming W. Pharmacologic and biologic properties of droloxifene, a new antiestrogen. Am J Clin Oncol 1991; 14 (Suppl 2): 5–14.
  • Kvinnsland S. Droloxifene, a new antiestrogen. Hormonal influences in post-menopausal breast cancer patients. Am J Clin Oncol 1991; 14 (Suppl 2): 46–51.
  • Jordan VC. Tamoxifen: toxicities and drug resistance during the treatment and prevention of breast cancer. Ann Rev Pharmacol Toxicol 1995; 35: 195–211.
  • Bruning PF. Droloxifene, a new anti-oestrogen in post-menopausal advanced breast cancer: preliminary results of a double-blind dose-finding phase II trial. Eur J Cancer 1992; 28A: 1404–7.
  • Rose C, Mourildsen HT. Endocrine therapy of advanced breast cancer. Acta Oncol 1988; 27: 721–8.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.